11/24/2023 0 Comments Copay accumulator![]() The State of Aging in America 2013, Specialty drugs are no longer restricted to rare and life-threatening conditions. The American population is aging into the part of life where disease is increasingly common each day, 10,000 Americans turn 65 - a pace that should continue through 2030, driving utilization of health care of all sorts. Specialty drugs make up roughly 40 percent of drug spending, or almost 7 percent of the total cost of health care, and that percentage is expected to continue to rise. Today the situation is radically different. In addition, there was very little competition, with only one drug available to treat a condition in most instances. Spending on specialty prescriptions per specialty drug user averaged just $2,641 per year. As recently as 2007, specialty drugs made up less than one percent of total health care spending and less than 7 percent of per-patient drug spending for Medicare and Medicaid. Historically, specialty drugs were used to treat rare or life-threatening conditions with small patient populations. Until recently, tools such as tiered formularies were not applicable - or needed - for specialty therapy classes. Through 2018, our managed formulary strategy is expected to deliver $13.4 billion in cumulative savings to our PBM clients through drug removals, inclusion of lower-cost brands, and transitioning members to generics.* Tiered formularies have been particularly effective in helping control spend in traditional drug classes. ![]() Our managed formulary strategy is expected to deliver $13.4B in cumulative savings through 2018
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |